Page 8 - Caredx News Today

CareDx, Inc (NASDAQ:CDNA – Get Rating) insider Reginald Seeto sold 2,818 shares of CareDx stock in a transaction on Monday, April 3rd. The shares were sold at an average price of $8.95, for a total transaction of $25,221.10. Following the completion of the transaction, the insider now owns 537,815 shares in the company, valued at […]

CareDx, Inc (NASDAQ:CDNA – Get Rating) has been given an average recommendation of “Hold” by the six brokerages that are covering the stock, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12 month target price among […]

Jounce Therapeutics said on Monday that it was ditching a planned merger with AIM-listed Redx Pharma, opting instead to be bought by Concentra Bioscences.

06.03.2023 - CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the Company ...

Lazard Asset Management LLC raised its position in CareDx, Inc (NASDAQ:CDNA – Get Rating) by 46.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,738 shares of the company’s stock after purchasing an additional 2,448 shares during the quarter. Lazard Asset Management LLC’s holdings […]

Renaissance Technologies LLC decreased its position in CareDx, Inc (NASDAQ:CDNA – Get Rating) by 21.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 760,400 shares of the company’s stock after selling 207,800 shares during the quarter. Renaissance Technologies […]

Guggenheim Capital LLC trimmed its position in CareDx, Inc (NASDAQ:CDNA – Get Rating) by 1.8% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 102,556 shares of the company’s stock after selling 1,913 shares during the period. Guggenheim Capital LLC owned about 0.19% of CareDx worth […]

16.02.2023 - CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers - today announced ... Seite 1

The signature event of Digital Lending Association of India- the annual DLAI conclave was held on Tuesday, January 24th amidst an august gathering of Digital lenders, Tech firms, Banks, NBFCs, Investors, Startups at the Taj Lands End, Mumbai.

06.12.2022 - Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into CareDx, Inc. (NasdaqGM: CDNA). On October 28, 2021, the Company ...